Tharimmune Inc (THAR)

[work-n-hard]

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=317895786&type=HTML&symbol=THAR&cdn=78571834fec680ac07cfd4519fc06783&companyName=Tharimmune+Inc.&formType=424B5&formDescription=Prospectus+%5BRule+424%28b%29%285%29%5D&dateFiled=2023-11-29

[Golden Cross]

Will it pop here

[Zorro]

So 11.5M shares worst case scenario. Almost traded that much today already.

[TheFinalCD]

https://tharimmune.com/pipeline/

[TheFinalCD]

THAR 1.02

HILS new 52 week low

[TheFinalCD]

$THAR S-1 OFFERING PRICED https://www.accesswire.com/viewarticle.aspx?id=810583

https://finviz.com/quote.ashx?t=THAR&ty=c&ta=1&p=d

$1.00 OFFER
https://dilutiontracker.com/app/search/THAR

Finding appropriate biomarkers for our potential drug candidates could limit our commercialization prospects and cause our losses to continue.



Any biomarker discovery or drug development that we are conducting may not be successful in identifying biomarkers that have commercial value for our products or therapeutic utility. Platforms may initially show promise in identifying potential biomarkers for our drug candidates, yet fail to stratify patients for clinical development or commercialization for a number of reasons, including, but not limited to:



? research programs to identify new biomarkers will require substantial technical, financial and human resources, and we may be unsuccessful in our efforts to identify biomarkers. If we are unable to identify suitable biomarkers for pre-clinical and clinical development, our ability to stratify patients could be compromised, which could result in significant harm to our financial position and adversely impact our stock price;

[Monksdream]

Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

Reverse split bullshit

[Awl416]

News?

[Monksdream]

THAR new 52 week low

[INFINITI]

Getting interesting here

[INFINITI]

Got some looks good and low float

[Golden Cross]

Popping here

[Sunset Kid]

Looks good, low float around 8 million. Less than 17M outstanding. .

[subslover]

INSANITY!

[subslover]

Strangely, no price was given on offering. https://www.otcmarkets.com/filing/html?id=17034238&guid=v65-kp-bmiM4B3h

[Awl416]

Going out on a limb but these Buyers AH are going to regret it

[velcro]

If HILS has the inside track on a cancer cure they must be keeping it a secret.

[Monksdream]

HILS new 52 week low

[hondaboost]

HILS, POS, lol.

[hondaboost]

PBTS, 0.22, running. Was $1.8 in June. O/S: 8 m.

[Monksdream]

HILS new 52 week low

[tw0122]

It’s obvious pump lol.. get in and out on the pumps. Quick 5% to be made and then hasta la vista. Bigger scheme of things you can say money printers go brrrrr starting at The Fed all the way down to big cap small Cap and otc stocks

[TheFinalCD]

https://www.globenewswire.com/news-release/2023/07/20/2708133/0/en/Hillstream-Advances-Next-Gen-Multispecific-Antibodies-for-Solid-Tumors-with-Lead-HER2-HER3-Program-HSB-3215.html

[Triple nickle]

Hmmmm is the tire losing air

[TheFinalCD]

lol why dont you just tell u swhy...


. This sponsorship was provided for compensation, this included a formal agreement between Moon Market LLC and Lifewater Media for a one-time fee of twenty five thousand USD for one placement to provide coverage on 7/19/2023-7/20/2023 for Hillstream BioPharma, Inc. (HILS).

[tw0122]

Run for the HILS tomorrow…

[BooDog]

This could get interesting very soon. https://ih.advfn.com/stock-market/NASDAQ/hillstream-biopharma-HILS/stock-news/91550551/form-8-k-current-report

[Triple nickle]

Hmmm fueled by social media talking heads

[surf1944]

I agree the SPO's have killed several biotech stocks and should be very good recovery plays, starting buying HILS yesterday. The year end rally for small cap biotech should be very good this year, making a watch list for Nov/Dec as well as playing bounces in the sector.

https://www.nasdaq.com/market-activity/spos

[BooDog]

Analysts are so far behind fundamental recoveries imo. This may likely be well over the $ by the time they get a clue. I'm more of a technical swing trader but I still snag a couple in the higher risk category.

HILS is being agressive imo. This is one bio that 'm saying the PPS is irrelevent (for now). The fund raising is about to pay off in the short term. Before any delisting.

Of course, if my DD is wrong, this could bleed to oblivion. But I think I'm good to go. We'll see sometime this summer if not sooner.

I'm accumulating, started around .44 and will take more.


Good to see you still around surf! Cheers.

[surf1944]

https://stockcharts.com/h-sc/ui?s=hils&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/hils/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/hils/opinion

[BooDog]

$HILS .4702 Randy Milby - CEO & Chairman
Mr. Milby was the former Chief Executive Officer and Member of the Board of Directors at CorMedix, a publicly traded biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of inflammatory and infectious diseases. A seasoned executive who led the increase in market capitalization from $3M to a peak of $350M of Cormedix while improving the company’s financial position with capital raises from equity markets. He oversaw efforts to gain CE Market approval of Neutrolin® in the European Union and held increasing roles of responsibility at Goldman Sachs and Dupont Merck prior in his career.
https://finviz.com/quote.ashx?t=CRMD&p=d

HILS
https://finviz.com/quote.ashx?t=HILS&ty=c&ta=1&p=d

https://hillstreambio.com/pipeline/

https://hillstreambio.com/quatramer/

Hillstream BioPharma Signs Exclusive Option Agreement with Applied Biomedical Science Institute (ABSI) to License Technology for HER2 and HER3 to be Developed for Potential Treatments Against Drug Resistant Cancers Including HER2-Positive Metastatic Breast Cancer, Gastric Cancer, Lung Cancer and Ovarian Cancer
https://hillstreambio.com/hillstream-biopharma-signs-exclusive-option-agreement-with-applied-biomedical-science-institute-absi-to-license-technology-for-her2-and-her3-to-be-developed-for-potential-treatments-against-drug-res/

I haven't been following HILS that long. And I'll be the first to tell you I'm no scientist or expert on drugs or thearapies. IF this venture works and can attack the solid tumors that will be a game changer imo. For me, this is where I look at risk/reward. Look back just to last Dec into January, this is back to testing those levels' Considering the fairly small float, I'm thinking if this gets the momentum into the beginning of trials with an IND filing this fall, well, this just may get there. Back over the $ that is.

cancer cells – causing them to rupture and stop replicating. An area of interest for the development of HSB-1216 are rare cancers with high unmet need.

[BooDog]

lol, yup. it's a wierd relationship when you like the science but everything takes forever. This is one of the riskiest sectors imo.

I'm wondering if they had news that was supposed to go out before the offering hit the streets.

[Awl416]

Yuck

[BooDog]

... today announced the pricing of an underwritten public offering of 5,300,000 shares of its common stock. Each share is being sold to the public at a price of $0.50 for gross proceeds of $2,650,000, before deducting underwriting discounts and offering expenses.
https://finance.yahoo.com/news/hillstream-biopharma-announces-pricing-public-015000928.html?guccounter=1&guce_referrer=aHR0cHM6Ly9maW52aXouY29tLw&guce_referrer_sig=AQAAAI4_s1gJ5aGKMrMChVdUMZq0KE9mQr_qZxTL76DKHrUgaMbxihXgHzuUtp95N2bQ-Mi1jnybno-kFwNEkKM-evYvLf_H4mhf1gBYnFNXrS8CCaYZqaBzxfsF1to7KOd-kFqz5OEMAFY6TLuCz0YbAyRmoKlAmA9qZQmOaekibALD

Have to say, this is all to easy to predict when a bio makes a move like HILS did. At least sometimes they do it with real news first and then after it sustains a decent run then the offering is announced a little higher than before the run started. Maybe a bit of speculation here but after watching BXRX do it, and now CFRX did their news I'm just waiting for their offering to post.

[Awl416]

News?

[gail]

still watching.

[gail]

nice dip here, i may get back in, not sure yet.

[gail]

and there she goes!

[gail]

going up on a/h trading, this board is soooo quiet, lol

[gail]

grabbed a few for the squeeze.

[bud_fox]

This still has a nasty gap to fill at .80. Be careful

[harry crumb]

Some upside today

[harry crumb]

Hold an have patience

[velcro]

Webcast was medical jargon for scientist researchers.

[velcro]

Anyone listen to the webcast?

[velcro]

Anyone listen to the webcast?

[harry crumb]

Yep

[subslover]

Got your MOJO rising $2.00

[subslover]

Got your MOJO rising $2.00